In addition to T cells, accumulating evidence demonstrates that other types of lymphocytes, including B cells and NK cells as well as tertiary lymphoid structures (TLS, a lymph node-like structure found in the tumor), play critical roles in anti-cancer immunity and are associated with the efficacy of anti-PD-(L)1 immunotherapy. This evidence concerns the gene CD274 and cancer.